TP53 and cancer: We show that mRNA poorly predicts UPS protein abundance, that a defined set of E3 ligases is recurrently dysregulated across cancers, and that somatic mutations (most strikingly <i>TP53</i> loss) produce coherent UPS protein-quantitative trait locus (pQTL) signatures.